Roche Holding AG (OTCMKTS:RHHBY) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have earned a consensus recommendation of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $51.50.

A number of equities research analysts recently commented on the company. HSBC lowered Roche from a “buy” rating to a “hold” rating in a research report on Monday, July 6th. Argus upgraded shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. Morgan Stanley upgraded shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a report on Friday, April 24th. Finally, Zacks Research lowered shares of Roche from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 14th.

Roche Stock Performance

Shares of OTCMKTS:RHHBY opened at $54.98 on Thursday. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72. Roche has a 12-month low of $37.51 and a 12-month high of $60.85. The business’s 50 day moving average is $51.70 and its 200 day moving average is $52.78.

Institutional Trading of Roche

Hedge funds have recently bought and sold shares of the business. OLD National Bancorp IN boosted its position in Roche by 0.7% in the first quarter. OLD National Bancorp IN now owns 257,854 shares of the company’s stock worth $12,623,000 after purchasing an additional 1,732 shares during the last quarter. S&CO Inc. increased its position in shares of Roche by 163.0% during the 1st quarter. S&CO Inc. now owns 140,551 shares of the company’s stock valued at $6,880,000 after purchasing an additional 87,107 shares during the last quarter. Opal Capital LLC purchased a new stake in shares of Roche during the 1st quarter valued at $4,448,000. Meritage Portfolio Management bought a new stake in shares of Roche during the 4th quarter worth $4,372,000. Finally, Hantz Financial Services Inc. boosted its holdings in shares of Roche by 164.9% in the 4th quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock worth $4,112,000 after buying an additional 49,633 shares during the last quarter.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.